The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Amantadine HCl Oral-Global Market Insights and Sales Trends 2025

Amantadine HCl Oral-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808686

No of Pages : 117

Ask Your Query
Synopsis
Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.
The global Amantadine HCl Oral market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Amantadine HCl Oral in various end use industries. The expanding demands from the Parkinson's Disease and Influenza, are propelling Amantadine HCl Oral market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Amantadine HCl Oral market, driven by demand from China, the second largest economy with some signs of stabilising, the Amantadine HCl Oral market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amantadine HCl Oral, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amantadine HCl Oral market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amantadine HCl Oral market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amantadine HCl Oral sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amantadine HCl Oral covered in this report include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals and Pharmaceutical Associates, Inc. (PAI), etc.
The global Amantadine HCl Oral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Global Amantadine HCl Oral market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amantadine HCl Oral market, Segment by Type:
Tablet
Capsules
Syrup
Global Amantadine HCl Oral market, by Application
Parkinson's Disease
Influenza
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Amantadine HCl Oral manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Amantadine HCl Oral in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Amantadine HCl Oral Market Overview
1.1 Amantadine HCl Oral Product Overview
1.2 Amantadine HCl Oral Market Segment by Type
1.2.1 Tablet
1.2.2 Capsules
1.2.3 Syrup
1.3 Global Amantadine HCl Oral Market Size by Type
1.3.1 Global Amantadine HCl Oral Market Size Overview by Type (2018-2029)
1.3.2 Global Amantadine HCl Oral Historic Market Size Review by Type (2018-2023)
1.3.3 Global Amantadine HCl Oral Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Amantadine HCl Oral Sales Breakdown by Type (2018-2023)
1.4.2 Europe Amantadine HCl Oral Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Amantadine HCl Oral Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Amantadine HCl Oral Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Amantadine HCl Oral Sales Breakdown by Type (2018-2023)
2 Global Amantadine HCl Oral Market Competition by Company
2.1 Global Top Players by Amantadine HCl Oral Sales (2018-2023)
2.2 Global Top Players by Amantadine HCl Oral Revenue (2018-2023)
2.3 Global Top Players by Amantadine HCl Oral Price (2018-2023)
2.4 Global Top Manufacturers Amantadine HCl Oral Manufacturing Base Distribution, Sales Area, Product Type
2.5 Amantadine HCl Oral Market Competitive Situation and Trends
2.5.1 Amantadine HCl Oral Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Amantadine HCl Oral Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amantadine HCl Oral as of 2022)
2.7 Date of Key Manufacturers Enter into Amantadine HCl Oral Market
2.8 Key Manufacturers Amantadine HCl Oral Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Amantadine HCl Oral Status and Outlook by Region
3.1 Global Amantadine HCl Oral Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Amantadine HCl Oral Historic Market Size by Region
3.2.1 Global Amantadine HCl Oral Sales in Volume by Region (2018-2023)
3.2.2 Global Amantadine HCl Oral Sales in Value by Region (2018-2023)
3.2.3 Global Amantadine HCl Oral Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Amantadine HCl Oral Forecasted Market Size by Region
3.3.1 Global Amantadine HCl Oral Sales in Volume by Region (2024-2029)
3.3.2 Global Amantadine HCl Oral Sales in Value by Region (2024-2029)
3.3.3 Global Amantadine HCl Oral Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Amantadine HCl Oral by Application
4.1 Amantadine HCl Oral Market Segment by Application
4.1.1 Parkinson's Disease
4.1.2 Influenza
4.2 Global Amantadine HCl Oral Market Size by Application
4.2.1 Global Amantadine HCl Oral Market Size Overview by Application (2018-2029)
4.2.2 Global Amantadine HCl Oral Historic Market Size Review by Application (2018-2023)
4.2.3 Global Amantadine HCl Oral Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Amantadine HCl Oral Sales Breakdown by Application (2018-2023)
4.3.2 Europe Amantadine HCl Oral Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Amantadine HCl Oral Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Amantadine HCl Oral Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Amantadine HCl Oral Sales Breakdown by Application (2018-2023)
5 North America Amantadine HCl Oral by Country
5.1 North America Amantadine HCl Oral Historic Market Size by Country
5.1.1 North America Amantadine HCl Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Amantadine HCl Oral Sales in Volume by Country (2018-2023)
5.1.3 North America Amantadine HCl Oral Sales in Value by Country (2018-2023)
5.2 North America Amantadine HCl Oral Forecasted Market Size by Country
5.2.1 North America Amantadine HCl Oral Sales in Volume by Country (2024-2029)
5.2.2 North America Amantadine HCl Oral Sales in Value by Country (2024-2029)
6 Europe Amantadine HCl Oral by Country
6.1 Europe Amantadine HCl Oral Historic Market Size by Country
6.1.1 Europe Amantadine HCl Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Amantadine HCl Oral Sales in Volume by Country (2018-2023)
6.1.3 Europe Amantadine HCl Oral Sales in Value by Country (2018-2023)
6.2 Europe Amantadine HCl Oral Forecasted Market Size by Country
6.2.1 Europe Amantadine HCl Oral Sales in Volume by Country (2024-2029)
6.2.2 Europe Amantadine HCl Oral Sales in Value by Country (2024-2029)
7 Asia-Pacific Amantadine HCl Oral by Region
7.1 Asia-Pacific Amantadine HCl Oral Historic Market Size by Region
7.1.1 Asia-Pacific Amantadine HCl Oral Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Amantadine HCl Oral Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Amantadine HCl Oral Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Amantadine HCl Oral Forecasted Market Size by Region
7.2.1 Asia-Pacific Amantadine HCl Oral Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Amantadine HCl Oral Sales in Value by Region (2024-2029)
8 Latin America Amantadine HCl Oral by Country
8.1 Latin America Amantadine HCl Oral Historic Market Size by Country
8.1.1 Latin America Amantadine HCl Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Amantadine HCl Oral Sales in Volume by Country (2018-2023)
8.1.3 Latin America Amantadine HCl Oral Sales in Value by Country (2018-2023)
8.2 Latin America Amantadine HCl Oral Forecasted Market Size by Country
8.2.1 Latin America Amantadine HCl Oral Sales in Volume by Country (2024-2029)
8.2.2 Latin America Amantadine HCl Oral Sales in Value by Country (2024-2029)
9 Middle East and Africa Amantadine HCl Oral by Country
9.1 Middle East and Africa Amantadine HCl Oral Historic Market Size by Country
9.1.1 Middle East and Africa Amantadine HCl Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Amantadine HCl Oral Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Amantadine HCl Oral Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Amantadine HCl Oral Forecasted Market Size by Country
9.2.1 Middle East and Africa Amantadine HCl Oral Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Amantadine HCl Oral Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Zydus Pharmaceuticals
10.1.1 Zydus Pharmaceuticals Company Information
10.1.2 Zydus Pharmaceuticals Introduction and Business Overview
10.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Products Offered
10.1.5 Zydus Pharmaceuticals Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Amantadine HCl Oral Products Offered
10.2.5 Mylan Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Amantadine HCl Oral Products Offered
10.3.5 Teva Recent Development
10.4 Vertical Pharmaceuticals
10.4.1 Vertical Pharmaceuticals Company Information
10.4.2 Vertical Pharmaceuticals Introduction and Business Overview
10.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Products Offered
10.4.5 Vertical Pharmaceuticals Recent Development
10.5 Adamas Pharmaceuticals
10.5.1 Adamas Pharmaceuticals Company Information
10.5.2 Adamas Pharmaceuticals Introduction and Business Overview
10.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Products Offered
10.5.5 Adamas Pharmaceuticals Recent Development
10.6 Upsher-Smith
10.6.1 Upsher-Smith Company Information
10.6.2 Upsher-Smith Introduction and Business Overview
10.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Upsher-Smith Amantadine HCl Oral Products Offered
10.6.5 Upsher-Smith Recent Development
10.7 Sandoz
10.7.1 Sandoz Company Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sandoz Amantadine HCl Oral Products Offered
10.7.5 Sandoz Recent Development
10.8 Mikart Pharmaceuticals
10.8.1 Mikart Pharmaceuticals Company Information
10.8.2 Mikart Pharmaceuticals Introduction and Business Overview
10.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Products Offered
10.8.5 Mikart Pharmaceuticals Recent Development
10.9 Pharmaceutical Associates, Inc. (PAI)
10.9.1 Pharmaceutical Associates, Inc. (PAI) Company Information
10.9.2 Pharmaceutical Associates, Inc. (PAI) Introduction and Business Overview
10.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Products Offered
10.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
10.10 Wockhardt Bio AG
10.10.1 Wockhardt Bio AG Company Information
10.10.2 Wockhardt Bio AG Introduction and Business Overview
10.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Wockhardt Bio AG Amantadine HCl Oral Products Offered
10.10.5 Wockhardt Bio AG Recent Development
10.11 CMP Pharma
10.11.1 CMP Pharma Company Information
10.11.2 CMP Pharma Introduction and Business Overview
10.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.11.4 CMP Pharma Amantadine HCl Oral Products Offered
10.11.5 CMP Pharma Recent Development
10.12 Bionpharma
10.12.1 Bionpharma Company Information
10.12.2 Bionpharma Introduction and Business Overview
10.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bionpharma Amantadine HCl Oral Products Offered
10.12.5 Bionpharma Recent Development
10.13 Graviti Pharma
10.13.1 Graviti Pharma Company Information
10.13.2 Graviti Pharma Introduction and Business Overview
10.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Graviti Pharma Amantadine HCl Oral Products Offered
10.13.5 Graviti Pharma Recent Development
10.14 Alembic Pharmaceuticals
10.14.1 Alembic Pharmaceuticals Company Information
10.14.2 Alembic Pharmaceuticals Introduction and Business Overview
10.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Products Offered
10.14.5 Alembic Pharmaceuticals Recent Development
10.15 Strides Pharma
10.15.1 Strides Pharma Company Information
10.15.2 Strides Pharma Introduction and Business Overview
10.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Strides Pharma Amantadine HCl Oral Products Offered
10.15.5 Strides Pharma Recent Development
10.16 Heritage Pharmaceuticals
10.16.1 Heritage Pharmaceuticals Company Information
10.16.2 Heritage Pharmaceuticals Introduction and Business Overview
10.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Products Offered
10.16.5 Heritage Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Amantadine HCl Oral Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Amantadine HCl Oral Industrial Chain Analysis
11.4 Amantadine HCl Oral Market Dynamics
11.4.1 Amantadine HCl Oral Industry Trends
11.4.2 Amantadine HCl Oral Market Drivers
11.4.3 Amantadine HCl Oral Market Challenges
11.4.4 Amantadine HCl Oral Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Amantadine HCl Oral Distributors
12.3 Amantadine HCl Oral Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock